il-17a conjugates and uses thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI HENGRUI PHARM CO LTD
- Publication Date
- 2018-02-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to an IL-17A conjugate and its use as a therapeutic agent, especially as a therapeutic agent for various inflammatory or autoimmune diseases. Background technique
[0002] The cytokines of the interleukin-17 family are named interleukin-17A to interleukin-17F, respectively. At the same time, people also found their receptor family: interleukin-17 receptor A to interleukin-17 receptor E. These interleukin-17 cytokines can bind to corresponding receptor members to mediate different inflammatory responses.
[0003] The most representative member of this family is interleukin-17A. Lymphocytes that migrate to infected or injured sites in the body secrete interleukin-17A. On the one hand, interleukin-17A can induce the expression of inflammatory factors and chemokines, thereby recruiting more immune cells to reach the inflammatory site and aggravate the inflammatory response; on the other hand, interleukin-17A can also induce...